The different markers like expression of Nrf2, NFκB-mediated signaling, and IL-6 expression need to be explored in detail to understand the mechanism of the bioactive compound against attenuating cardiomyopathy in diabetic rats. This evidence concerns the gene NFKB1 and cardiomyopathy.